UK may switch Arthriex for osteoarthritis of knee

14 July 2017 - Deborah Wilkes

Archived

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is consulting on a proposal to switch Arthriex tablets containing glucosamine sulfate from prescription to non-prescription status for relieving osteoarthritis of the knee.

Click tags below for more information on topics:

MHRA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: